Home/Filings/4/0001214659-22-012399
4//SEC Filing

Goldfarb Robert I 4

Accession 0001214659-22-012399

CIK 0001625288other

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 12:45 PM ET

Size

7.0 KB

Accession

0001214659-22-012399

Insider Transaction Report

Form 4
Period: 2022-10-17
Goldfarb Robert I
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2022-10-17+250,0001,528,800 total
  • Award

    Options to purchase common stock (right to buy)

    2020-08-19+1,000,0001,000,000 total
    Exercise: $0.08From: 2020-08-19Exp: 2027-08-19Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]Issued in lieu of compensation for services.

Issuer

NEXIEN BIOPHARMA, INC.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001337910

Filing Metadata

Form type
4
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 12:45 PM ET
Size
7.0 KB